LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 GW843682X
1.11
uM
LJP6
 0.3184 0.0258 -0.1378 0.0937
SK-BR-3 HG-5-113-01
1.11
uM
LJP5
 0.4311 0.0751 0.0646 0.0879
SK-BR-3 HG-5-88-01
1.11
uM
LJP6
 0.7963 0.0170 0.6579 0.0438
SK-BR-3 Imatinib
1.11
uM
LJP6
 1.0355 0.0274 1.0537 0.0420
SK-BR-3 JNK-9L
1.11
uM
LJP6
 0.4764 0.0269 0.1311 0.0378
SK-BR-3 JW-7-24-1
1.11
uM
LJP6
 0.6501 0.0180 0.4197 0.0188
SK-BR-3 Lapatinib
1.11
uM
LJP6
 0.3952 0.0157 -0.0074 0.0597
SK-BR-3 LDN-193189
1.11
uM
LJP5
 1.0095 0.0236 1.0202 0.0419
SK-BR-3 Linifanib
1.11
uM
LJP6
 1.0468 0.0341 1.0745 0.0574
SK-BR-3 Linsitinib
1.11
uM
LJP5
 0.8430 0.0312 0.7417 0.0477
SK-BR-3 Mitoxantrone
1.11
uM
LJP5
 0.3316 0.0372 -0.1131 0.0855
SK-BR-3 Mitoxantrone
1.11
uM
LJP6
 0.2961 0.0322 -0.1759 0.1060
SK-BR-3 MK2206
1.11
uM
LJP6
 0.6316 0.0235 0.3894 0.0252
SK-BR-3 Neratinib
1.11
uM
LJP5
 0.3354 0.0377 -0.1128 0.1209
SK-BR-3 Nilotinib
1.11
uM
LJP5
 1.1029 0.0223 1.1689 0.0303
SK-BR-3 Nintedanib
1.11
uM
LJP6
 0.8746 0.0105 0.7929 0.0086
SK-BR-3 NU7441
1.11
uM
LJP5
 0.8321 0.0478 0.7156 0.0844
SK-BR-3 Dactolisib
1.11
uM
LJP5
 0.3752 0.0332 -0.0385 0.0623
SK-BR-3 NVP-TAE684
1.11
uM
LJP6
 0.7881 0.0530 0.6492 0.0871
SK-BR-3 Palbociclib
1.11
uM
LJP6
 0.7301 0.0066 0.5513 0.0172
SK-BR-3 PD0325901
1.11
uM
LJP5
 0.8383 0.0137 0.7330 0.0081
SK-BR-3 PD0325901
1.11
uM
LJP6
 0.8136 0.0247 0.6941 0.0223
SK-BR-3 PD173074
1.11
uM
LJP6
 1.0693 0.0462 1.1122 0.0777
SK-BR-3 PD184352
1.11
uM
LJP5
 1.0335 0.0057 1.0547 0.0066
SK-BR-3 Pelitinib
1.11
uM
LJP5
 0.3465 0.0307 -0.0907 0.0941